Gilead Sciences Inc. Q4 Profit Increases, beats estimates

Gilead Sciences Inc. (GILD) reported earnings for its fourth quarter that increased from the same period last year and beat the Street estimates.

The company's bottom line totaled $1.64 billion, or $1.30 per share. This compares with $382 million, or $0.30 per share, in last year's fourth quarter.

Excluding items, Gilead Sciences Inc. reported adjusted earnings of $1.67 per share for the period.

Analysts on average had expected the company to earn $1.49 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter rose 2.1% to $7.39 billion from $7.24 billion last year.

Gilead Sciences Inc. earnings at a glance (GAAP) :

-Earnings (Q4): $1.64 Bln. vs. $382 Mln. last year.
-EPS (Q4): $1.30 vs. $0.30 last year.
-Analyst Estimate: $1.49
-Revenue (Q4): $7.39 Bln vs. $7.24 Bln last year.

For comments and feedback contact: editorial@rttnews.com

Follow RTT